Litcius/Paper detail

Diagnostic and therapeutic nanoenzymes for enhanced chemotherapy and photodynamic therapy

Cong Cong, Yuchu He, Shuxian Zhao, Xuwu Zhang, Lei Li, Desong Wang, Lanxiang Liu, Dawei Gao

2021Journal of Materials Chemistry B37 citationsDOI

Abstract

Nanozymes, as a kind of artificial mimic enzymes, have superior catalytic capacity and stability. As lack of O2 in tumor cells can cause resistance to drugs, we designed drug delivery liposomes (MnO2-PTX/Ce6@lips) loaded with catalase-like nanozymes of manganese dioxide nanoparticles (MnO2 NPs), paclitaxel (PTX) and chlorin e6 (Ce6) to consume tumor's native H2O2 and produce O2. Based on the catalysis of MnO2 NPs, a large amount of oxygen was produced by MnO2-PTX/Ce6@lips to burst the liposomes and achieve a responsive release of the loaded drug (paclitaxel), and the released O2 relieved the chemoresistance of tumor cells and provided raw materials for photodynamic therapy. Subsequently, MnO2 NPs were decomposed into Mn2+ in an acidic tumor environment to be used as contrast agents for magnetic resonance imaging. The MnO2-PTX/Ce6@lips enhanced the efficacy of chemotherapy and photodynamic therapy (PDT) in bearing-tumor mice, even achieving complete cure. These results indicated the great potential of MnO2-PTX/Ce6@lips for the modulation of the TME and the enhancement of chemotherapy and PDT along with MRI tracing in the treatment of tumors.

Topics & Concepts

Photodynamic therapyMaterials scienceLiposomeChemotherapyNanotechnologyCatalaseCatalysisCancer researchMedicineChemistryInternal medicineBiochemistryOrganic chemistryOxidative stressNanoplatforms for cancer theranosticsAdvanced Nanomaterials in CatalysisNanocluster Synthesis and Applications
Diagnostic and therapeutic nanoenzymes for enhanced chemotherapy and photodynamic therapy | Litcius